Chapter 5 CXCL14 and Insulin Action

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 107-123

  Hara, Takahiko ^a   Nakayama, Yuki ^a,b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Adipokine; BRAK; Chemokine; CXCL14; Insulin resistance; Macrophage; Obesity

Indexed keywords

ALPHA CHEMOKINE; CXCL14 PROTEIN, MOUSE; INSULIN; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BODY WEIGHT; CYTOLOGY; DIET; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; OBESITY; PHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; AMINO ACID SEQUENCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHEMOKINES, CXC; DIET; FEMALE; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OBESITY; RNA, MESSENGER;

EID: 61349150089     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00605-5     Document Type: Review

References (40)

1. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
2. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
3. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., and Strieter R.M. CXC chemokines in angiogenesis. J. Leukoc. Biol. 68 (2000) 1-8
4. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
5. Cao X., Zhang W., Wan T., He L., Chen T., Yuan Z., Ma S., Yu Y., and Chen G. Molecular cloning and characterization of a novel CXC chemokine macrophage inflammatory protein-2 gamma chemoattractant for human neutrophils and dendritic cells. J. Immunol. 165 (2000) 2588-2595
6. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D.J., Reitman M.L., and Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 13 (2005) 1311-1320
7. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El-Naggar A.K., and Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol. 156 (2000) 1937-1950
8. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
9. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson II K., Azam M., and Hou Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255 (1999) 703-706
10. Huising M.O., van der Meulen T., Flik G., and Verburg-van Kemenade B.M. Three novel carp CXC chemokines are expressed early in ontogeny and at nonimmune sites. Eur. J. Biochem. 271 (2004) 4094-4106
11. Inouye K.E., Shi H., Howard J.K., Daly C.H., Lord G.M., Rollins B.J., and Flier J.S. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56 (2007) 2242-2250
12. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281 (2006) 26602-26614
13. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K.I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., and Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116 (2006) 1494-1505
14. Kirk E.A., Sagawa Z.K., McDonald T.O., O'Brien K.D., and Heinecke J.W. Macrophage chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes 57 (2008) 1254-1261
15. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., and Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194 (2001) 855-861
16. Meuter S., Schaerli P., Roos R.S., Brandau O., Bosl M.R., von Andrian U.H., and Moser B. Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol. Cell. Biol. 27 (2007) 983-992
17. Nara N., Nakayama Y., Okamoto S., Tamura H., Kiyono M., Muraoka M., Tanaka K., Taya C., Shitara H., Ishii R., Yonekawa H., Minokoshi Y., et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J. Biol. Chem. 282 (2007) 30794-30803
18. Nelson P.J., and Krensky A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14 (2001) 377-386
19. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., Zalevsky J., Dahiyat B.I., Chi N.W., and Olefsky J.M. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 35361-35371
20. Ogawa S., Lozach J., Jepsen K., Sawka-Verhelle D., Perissi V., Sasik R., Rose D.W., Johnson R.S., Rosenfeld M.G., and Glass C.K. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl. Acad. Sci. USA 101 (2004) 14461-14466
21. Ozawa S., Kato Y., Komori R., Maehata Y., Kubota E., and Hata R. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem. Biophys. Res. Commun. 348 (2006) 406-412
22. Peterson F.C., Thorpe J.A., Harder A.G., Volkman B.F., and Schwarze S.R. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome. J. Mol. Biol. 363 (2006) 813-822
23. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100 (2003) 7265-7270
24. Schaerli P., Willimann K., Ebert L.M., Walz A., and Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for langerhans cell differentiation. Immunity 23 (2005) 331-342
25. Schwarze S.R., Luo J., Isaacs W.B., and Jarrard D.F. Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 64 (2005) 67-74
26. Shellenberger T.D., Wang M., Gujrati M., Jayakumar A., Strieter R.M., Burdick M.D., Ioannides C.G., Efferson C.L., El-Naggar A.K., Roberts D., Clayman G.L., and Frederick M.J. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 64 (2004) 8262-8270
27. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341 (1999) 248-257
28. Shurin G.V., Ferris R., Tourkova I.L., Perez L., Lokshin A., Balkir L., Collins B., Chatta G.S., and Shurin M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol. 174 (2005) 5490-5498
29. Sleeman M.A., Fraser J.K., Murison J.G., Kelly S.L., Prestidge R.L., Palmer D.J., Watson J.D., and Kumble K.D. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int. Immunol. 12 (2000) 677-689
30. Starnes T., Rasila K.K., Robertson M.J., Brahmi Z., Dahl R., Christopherson K., and Hromas R. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: Implications for the downregulation of CXCL14 in malignancy. Exp. Hematol. 34 (2006) 1101-1105
31. Takahashi K., Mizuarai S., Araki H., Mashiko S., Ishihara A., Kanatani A., Itadani H., and Kotani H. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278 (2003) 46654-46660
32. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Iida K., Okimura Y., Kaji H., and Chihara K. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity. Biochem. Biophys. Res. Commun. 364 (2007) 1037-1042
33. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
34. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
35. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., and Ferrante A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116 (2006) 115-124
36. Wente M.N., Mayer C., Gaida M.M., Michalski C.W., Giese T., Bergmann F., Giese N.A., Buchler M.W., and Friess H. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett. 259 (2008) 209-217
37. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
38. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
39. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., Kotani K., Quadro L., and Kahn B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
40. Zlotnik A., and Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 12 (2000) 121-127